Balanced news tone
News Sentiment
BLISSGVS sentiment intelligence
Bliss GVS Pharma Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
56
Balanced news tone
29 relevant articles
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+11.1% over one week, +61.9% over four weeks, trend active, and materially above fair value.
Bliss GVS Pharma fixes record date for FY26 dividend
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
80/100 classification
One-week reaction
11.1%
Price confirming higher
Trend fit
Trend active
61.9% over four weeks
Fair value
227.6%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
8
Neutral
21
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
scanx.trade
Direct company coverage
Bliss GVS Pharma fixes record date for FY26 dividend
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 19 Jun 2026 09:59
- Source
- scanx.trade
India Infoline
Direct company coverage
Bliss GVS Pharma Ltd hits 52-week high of ₹447 Amid WHO Approval, Strong Earnings and Acquisition Boost
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 03 Jun 2026 07:00
- Source
- India Infoline
CNBC TV18
Direct company coverage
Here's why Bliss GVS Pharma shares have surged over 45% over the last 10 sessions
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- CNBC TV18
Moneycontrol.com
Direct company coverage
Bliss GVS Pharma shares hits 52-week high on inspection closure report from WHO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Moneycontrol.com
Moneycontrol.com
Direct company coverage
Stocks to Watch Today: Infosys, Bliss GVS Pharma, Vedanta, John Cockerill, Concord Biotech, Rajnandini...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Moneycontrol.com
Moneycontrol.com
Direct company coverage
Buzzing Stocks: John Cockerill up 7% on order win; Bliss GVS hits 52-week high on inspection closure...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Moneycontrol.com
scanx.trade
Direct company coverage
Anupam Rasayan offers ₹299 per share for Bliss GVS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Should You Be Adding Bliss GVS Pharma (NSE:BLISSGVS) To Your Watchlist Today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 May 2026 07:00
- Source
- simplywall.st
The Economic Times
Direct company coverage
Bliss GVS Pharma - Multibaggers: 15 stocks with 25%+ sales and profit growth in Q4 March 2026
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 29 May 2026 07:00
- Source
- The Economic Times
The Economic Times
Direct company coverage
Bliss GVS Pharma - Multibaggers: 12 stocks with profit margins above 10% for 4 straight quarters. Do you own any?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 27 May 2026 07:00
- Source
- The Economic Times
Moneycontrol.com
Direct company coverage
Bliss GVS hits 20% upper circuit as Anupam Rasayan to acquire up to 43% stake for Rs 1,369 crore
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 26 May 2026 07:00
- Source
- Moneycontrol.com
Fortune India
Direct company coverage
Anupam Rasayan enters pharma space with Bliss GVS deal; stock slips 4% from day’s high
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 25 May 2026 07:00
- Source
- Fortune India
BusinessLine
Direct company coverage
Stocks to Watch, May 25: Anupam Rasayan, Bliss GVS, Oil India, NBCC, RVNL, Lupin, Aurobindo Pharma, CBI
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- BusinessLine
scanx.trade
Direct company coverage
Anupam Rasayan to acquire up to 74.20% in Bliss GVS for ₹2,198 crore
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Bliss GVS Pharma Independent Director Santosh Parab completes term
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Anupam Rasayan launches ₹829 cr open offer for Bliss GVS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- scanx.trade
NDTV Profit
Direct company coverage
Anupam Rasayan To Acquire Up to 43% Stake In Bliss GVS Pharma For Around Rs 1,369 Crore
- Tone
- Positive 58/100
- Event
- Deals and strategy
- Published
- 24 May 2026 07:00
- Source
- NDTV Profit
CNBC TV18
Direct company coverage
Anupam Rasayan enters formulations business with ₹1,369 cr Bliss GVS Pharma acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 23 May 2026 07:00
- Source
- CNBC TV18
The Economic Times
Direct company coverage
Bliss GVS Pharma - These 14 smallcap stocks rally up to 250% in just 6 months; 4 turn multibaggers
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 07:00
- Source
- The Economic Times
scanx.trade
Direct company coverage
Bliss GVS Pharma Board Meeting Scheduled on May 12, 2026 to Approve Q4 FY26 Results and Final Dividend
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- scanx.trade
NDTV Profit
Direct company coverage
Five Stocks To Buy: Welspun Corp, J&K Bank, Bliss GVS, FACT, And Newgen Software
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- NDTV Profit
simplywall.st
Direct company coverage
Be Sure To Check Out Bliss GVS Pharma Limited (NSE:BLISSGVS) Before It Goes Ex-Dividend
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Feb 2026 08:00
- Source
- simplywall.st
scanx.trade
Direct company coverage
Bliss GVS Pharma Publishes Q3FY26 Results in Newspapers Under SEBI Regulation 47
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Feb 2026 08:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Bliss GVS Pharma Clarifies Media Reports on Potential Anupam Rasayan Stake Acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 12 Feb 2026 08:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Bliss GVS Pharma's (NSE:BLISSGVS) 37% CAGR outpaced the company's earnings growth over the same three-year period
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 07 Jan 2026 08:00
- Source
- simplywall.st
The Economic Times
Direct company coverage
Bliss GVS Pharma - Positive Breakout: These 10 stocks cross above their 200 DMAs
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 Dec 2025 08:00
- Source
- The Economic Times
simplywall.st
Direct company coverage
Bliss GVS Pharma Limited (NSE:BLISSGVS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Dec 2025 08:00
- Source
- simplywall.st
scanx.trade
Direct company coverage
Bliss GVS Pharma Grants 5.53 Lakh Stock Options to Employees at 72% Discount
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Nov 2025 08:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Here's Why Shareholders Will Not Be Complaining About Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Pay Packet
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jul 2025 07:00
- Source
- simplywall.st